Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions

Background: The Bath Ankylosing Spondylitis Metrology Index (BASMI) characterises the spinal mobility of patients with ankylosing spondylitis. Two versions have been published using categorical scores with either scores 0–2 for each of the five assessments, or scores 0–10. For metric purposes, we recently defined a BASMI version with linear score definitions. Aim: to evaluate agreement between three BASMI definitions and to test sensitivity to change. Patients and methods: The performance of the BASMI2 (based on the 2-step definition), BASMI10 (based on the 10-step definition), and BASMIlin (based on the linear definition), are compared in 598 status assessments and 222 follow-up assessments with a 24-week interval after an intervention with either placebo or a tumour necrosis factor (TNF) blocker from various cohorts of patients with ankylosing spondylitis (AS). Descriptive statistics and Bland–Altman plots were applied to compare the pairwise agreement of the three definitions. To assess sensitivity to change, Guyatt effect size using change data from the placebo and actively treated patients were used. Results: Bland–Altman analysis showed that the differences between BASMI2 scores and scores obtained by either of the two other definitions were highly dependent on the magnitude of the measurement. Guyatt effect sizes were 0.66 for the BASMI2, 0.95 for the BASMI10, and 1.04 for the BASMIlin, respectively, demonstrating best sensitivity to change for the newly-developed BASMIlin. Conclusions: The BASMI10 and BASMIlin have clear metric advantages as compared to BASMI2, among which are their superior sensitivity to change and feasibility of BASMIlin in computer evaluations. The BASMI10 and BASMI2 are not interchangeable.

[1]  A Calin,et al.  Ankylosing spondylitis: the correlation between a new metrology score and radiology. , 1995, British journal of rheumatology.

[2]  S. van der Linden,et al.  Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists , 2004, Annals of the rheumatic diseases.

[3]  M. Dougados,et al.  A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. , 1999, The Journal of rheumatology.

[4]  M. Dougados,et al.  Determinants of hyperkyphosis in patients with ankylosing spondylitis , 2005, Annals of the rheumatic diseases.

[5]  M. Dougados,et al.  Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? , 2005, Annals of the rheumatic diseases.

[6]  M. Dougados,et al.  Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. , 2004, The Journal of rheumatology.

[7]  A. Calin,et al.  A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) , 1995, The Journal of rheumatology.

[8]  M. Dougados,et al.  Assessment of enthesitis in ankylosing spondylitis , 2003, Annals of the rheumatic diseases.

[9]  A Calin,et al.  Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. , 1994, The Journal of rheumatology.

[10]  D. Altman,et al.  Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.